Search Results for: %22Catherine price%22
...know, semaglutide is a very expensive drug. The New York Times reports that the dosage used to treat diabetes today has an average retail price of about $1,000 a month; and the weight loss study used significantly larger doses. Second, while side effects were “transient” and “mild-to-moderate in severity,” they...
...a natural incentive to become more efficient and offer lower prices, benefitting the consumer. But in the world of insulin, literally the opposite occurs. The report found that, for example, whenever Sanofi raised the price of its insulins, Novo Nordisk would respond by raising its own prices by a similar...
...Dexcom worried about the controversy? Probably not too much. The ad certainly did its job: the company’s visibility skyrocketed overnight, and apparently its stock price even went up. A Dexcom spokesman told Esquire that “running an ad during the Super Bowl is one of the most impactful ways to support...
...not as likely to take advantage of these sorts of subscription services—none of which are covered by insurance—their spread can only be good news for the diabetes community. The more people interested in glucose monitoring technology, the more businesses will be motivated to innovate and compete on price. If CGM...
...that pushed for the approval. There’s no word yet on the cost Amphastar’s generic glucagon injection. A representative told ace Medscape reporter Miriam Tucker, “We are confident that our generic to Lilly’s time-tested glucagon will provide a favorable option, at a reasonable price, to patients who rely on this product.”...
...see the G7 in the second half of 2021. The company is planning to sell a lot of these, and in anticipation of huge demand they are levelling up their manufacturing capabilities. Dexcom says this will also help keep the price down. Our friends at Diabetes Daily have more details...
...few patients can pay the full out-of-pocket price, and Dexcom has often had an uphill climb in convincing insurers to cover it. When we spoke to Dexcom CEO Kevin Sayers last year, he revealed that insurance companies are still somewhat trigger shy based on past experience, given that more primitive...
...this is one of the most urgent issues for the state. Insulin prices have skyrocketed, tripling in price between 2002 and 2013, and $360 million is spent treating diabetes and its complications in Vermont each year. It is critical that elected officials address the needs of their citizens with diabetes.”...
...in the smallest and thinnest sensor design at the same affordable price as previous versions of the device. With a 14-day wear time, the FreeStyle Libre 3 system includes the longest-lasting, self-applied CGM sensor available. The sensor is easy to apply with a one-piece applicator and is worn on the...